# Levamisole and Isoprinosine in Immune-prophylaxis of Egyptian Healthcare Workers Facing COVID-19

> **NCT04360122** · PHASE3 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 100 (estimated)

## Conditions studied

- Coronavirus Disease (COVID-19)

## Interventions

- **DRUG:** Levamisole
- **DRUG:** Isoprinosine
- **DRUG:** Levamisole and Isoprinosine

## Key facts

- **NCT ID:** NCT04360122
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-20
- **Primary completion:** 2020-11-01
- **Final completion:** 2020-12-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04360122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04360122, "Levamisole and Isoprinosine in Immune-prophylaxis of Egyptian Healthcare Workers Facing COVID-19". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04360122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*